Anders G. Pedersen

692 total citations
27 papers, 538 citations indexed

About

Anders G. Pedersen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Anders G. Pedersen has authored 27 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Anders G. Pedersen's work include Lung Cancer Research Studies (12 papers), Neuroendocrine Tumor Research Advances (11 papers) and Brain Metastases and Treatment (9 papers). Anders G. Pedersen is often cited by papers focused on Lung Cancer Research Studies (12 papers), Neuroendocrine Tumor Research Advances (11 papers) and Brain Metastases and Treatment (9 papers). Anders G. Pedersen collaborates with scholars based in Denmark, Australia and Netherlands. Anders G. Pedersen's co-authors include Heine H. Hansen, Flemming W. Bach, Paul E.G. Kristjansen, P Dombernowsky, Mogens Hansen, M Hansen, Steen Werner Hansen, Per Bech, Henning Friis Andersen and P. Tanghøj and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Neurology.

In The Last Decade

Anders G. Pedersen

24 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders G. Pedersen Denmark 13 292 188 163 130 83 27 538
M. Martin Belgium 14 159 0.5× 73 0.4× 19 0.1× 320 2.5× 47 0.6× 24 710
T.K. Wheeler United Kingdom 10 135 0.5× 70 0.4× 40 0.2× 57 0.4× 18 0.2× 19 459
S. M. Doherty United Kingdom 6 253 0.9× 61 0.3× 38 0.2× 208 1.6× 13 0.2× 9 713
Abe K Japan 9 66 0.2× 74 0.4× 53 0.3× 77 0.6× 23 0.3× 99 391
Amethyst Leimpeter United States 17 85 0.3× 132 0.7× 103 0.6× 61 0.5× 13 0.2× 24 783
Anne E. Kayl United States 7 123 0.4× 184 1.0× 83 0.5× 64 0.5× 11 0.1× 7 547
Masaya Enomoto Japan 8 86 0.3× 92 0.5× 114 0.7× 99 0.8× 27 0.3× 19 477
Yangyang Feng China 12 94 0.3× 74 0.4× 41 0.3× 360 2.8× 41 0.5× 20 731
Carin Muhr Sweden 20 54 0.2× 39 0.2× 220 1.3× 81 0.6× 32 0.4× 45 919

Countries citing papers authored by Anders G. Pedersen

Since Specialization
Citations

This map shows the geographic impact of Anders G. Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders G. Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders G. Pedersen more than expected).

Fields of papers citing papers by Anders G. Pedersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders G. Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders G. Pedersen. The network helps show where Anders G. Pedersen may publish in the future.

Co-authorship network of co-authors of Anders G. Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Anders G. Pedersen. A scholar is included among the top collaborators of Anders G. Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders G. Pedersen. Anders G. Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pedersen, Anders G., et al.. (2009). METRIZAMID MYELOGRAPHY IN PATIENTS WITH MENINGEAL CARCINOMATOSIS. Acta Neurologica Scandinavica. 65(S90). 100–100.
2.
Pedersen, Anders G.. (2006). Citalopram and suicidality in adult major depression and anxiety disorders. Nordic Journal of Psychiatry. 60(5). 392–399. 6 indexed citations
3.
Pedersen, Anders G.. (2005). Escitalopram and suicidality in adult depression and anxiety. International Clinical Psychopharmacology. 20(3). 139–143. 35 indexed citations
4.
Bech, Per, P. Tanghøj, P. Cialdella, Henning Friis Andersen, & Anders G. Pedersen. (2004). Escitalopram dose–response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression. The International Journal of Neuropsychopharmacology. 7(3). 283–290. 61 indexed citations
5.
Kristjansen, Paul E.G., Anders G. Pedersen, Bjørn Quistorff, & Mogens Spang‐Thomsen. (1992). Different early effect of irradiation in brain and small cell lung cancer examined by in vivo 31P-magnetic resonance spectroscopy. Radiotherapy and Oncology. 24(3). 186–190. 4 indexed citations
6.
Vibe-Petersen, Jette, Flemming W. Bach, Anders G. Pedersen, John Smyth, & Heine H. Hansen. (1989). A phase II trial of TCNU in patients with squamous, adeno and large cell carcinoma of the lung. European Journal of Cancer and Clinical Oncology. 25(12). 1881–1885. 9 indexed citations
7.
Bach, Flemming W., et al.. (1989). Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancer. European Journal of Cancer and Clinical Oncology. 25(12). 1703–1709. 15 indexed citations
8.
Pedersen, Anders G., James F. Bishop, Norman M. Bleehen, et al.. (1989). Management of CNS metastases in small cell lung cancer: a consensus report. Lung Cancer. 5(4-6). 140–142. 10 indexed citations
9.
Pedersen, Anders G., Paul E.G. Kristjansen, & Heine H. Hansen. (1988). Prophylactic cranial irradiation and small cell lung cancer. Cancer Treatment Reviews. 15(2). 85–103. 47 indexed citations
10.
Hansen, Steen Werner, et al.. (1987). Detection of liver metastases in small-cell lung cancer: a comparison of peritoneoscopy with liver biopsy and ultrasonography with fine-needle aspiration.. Journal of Clinical Oncology. 5(2). 255–259. 10 indexed citations
12.
Hansen, Mogens & Anders G. Pedersen. (1986). Tumor Markers in Patients with Lung Cancer. CHEST Journal. 89(4). 219S–224S. 35 indexed citations
13.
Groth, S., et al.. (1986). Acute and long-term nephrotoxicity of cis-platinum in man. Cancer Chemotherapy and Pharmacology. 17(2). 191–196. 58 indexed citations
14.
Pedersen, Anders G., Flemming W. Bach, & B Melgaard. (1985). Frequency, diagnosis, and prognosis of spinal cord compression in small cell bronchogenic carcinoma. A review of 817 consecutive patients. Cancer. 55(8). 1818–1822. 25 indexed citations
15.
Pedersen, Anders G., et al.. (1985). Cerebrospinal fluid ACTH as a marker of central nervous system metastases from small cell carcinoma of the lung. Cancer. 56(10). 2476–2480. 7 indexed citations
16.
Pedersen, Anders G. & Heine H. Hansen. (1983). Etoposide (VP-16) in the treatment of lung cancer. Cancer Treatment Reviews. 10(4). 245–264. 47 indexed citations
17.
Pedersen, Anders G., et al.. (1983). Brain CT-scanning and neurological examination in small cell bronchogenic carcinoma. Journal of Neuro-Oncology. 1(3). 197–202. 7 indexed citations
18.
Melgaard, B, Hanne Sand Hansen, Z Kamieniecka, et al.. (1982). Misonidazole neuropathy: A clinical, electrophysiological and histological study. Annals of Neurology. 12(1). 10–17. 14 indexed citations
19.
Groth, S., et al.. (1982). Nephrotoxicity of cisplatinum in man. A method for early detection. 1 indexed citations
20.
Pedersen, Anders G., et al.. (1980). Current quality problems at the dairy plant.. 93(10). 280–284.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026